Consumer Driven Health Care

The cost of prescription drugs has risen steadily over the past decade and shows no sign of stopping.

There may not be many individuals with health savings accounts who use the investment option such accounts offer, but those who do contribute more, and their balances are larger.

Sprouts controversial "female Viagra" pill received approval on Tuesday from the FDA--now Valeant is buying Sprout.

Anthem, the third-largest health insurer in the country, said Wednesday it will cover Sprout Pharmaceuticals "female Viagra" pill Addyi in many cases. But others aren't sure yet.

Sprout Pharmaceuticals' female libido drug Addyi will be available as soon as Oct. 17, despite its modest benefit and serious side effects. The FDA had previously rejected the drug in 2013, then faced a backlash from some doctors and researchers.

The FTC is cracking down on agreements between pharmaceutical companies on the sale of generic drugs--this time between Concordia Healthcare and Par Pharmaceutical.